linea guida aiom - terapia del dolore in oncologia - Azienda USL di ...
linea guida aiom - terapia del dolore in oncologia - Azienda USL di ...
linea guida aiom - terapia del dolore in oncologia - Azienda USL di ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Bibliografia<br />
1. Breivik H, Cherny N, Collett B, et al. Cancer-related pa<strong>in</strong>: A pan-european survey of prevalence,<br />
treatment, and patient attitudes. Ann Oncol, 2009 Feb 26. [Epub ahead of pr<strong>in</strong>t]<br />
2. Hanks GW, Conno F, Cherny N, et al. Morph<strong>in</strong>e and alternative opioids <strong>in</strong> cancer pa<strong>in</strong>: The<br />
EAPC recommendations. Br J Cancer 2001; 84:587-593<br />
3. World Health Organization: Cancer Pa<strong>in</strong> Relief, Second E<strong>di</strong>tion, with a Guide to Opioid<br />
Availability. Geneva, 1996<br />
4. Deandrea S, Montanari M, Moja L, et al. Prevalence of undertreatment <strong>in</strong> cancer pa<strong>in</strong>. A review<br />
of published literature. Ann Oncol 2008; 19:1985-1991<br />
5. Jensen MP. The vali<strong>di</strong>ty and reliability of pa<strong>in</strong> measures <strong>in</strong> adults with cancer. J Pa<strong>in</strong> 2003; 4:2-<br />
21<br />
6. Holen JC, Hjermstad MJ, Loge JH, et al. Pa<strong>in</strong> assessment tools: Is the content appropriate for use<br />
<strong>in</strong> palliative care? J Pa<strong>in</strong> Symptom Manage 2006; 32: 567-580<br />
7. Hjermstad MJ, Gibb<strong>in</strong>s J, Haugen DF, et al. Pa<strong>in</strong> assessment tools <strong>in</strong> palliative care: An urgent<br />
need for consensus. Palliat Med 2008; 22:895-903<br />
8. Caraceni A, Cherny N, Fa<strong>in</strong>s<strong>in</strong>ger R, et al. Pa<strong>in</strong> measurement tools and methods <strong>in</strong> cl<strong>in</strong>ical<br />
research <strong>in</strong> palliative care. Recommendations of an expert work<strong>in</strong>g group of the european<br />
association of palliative care. J Pa<strong>in</strong> Symptom Manage 2002; 23:239-255<br />
9. Dwork<strong>in</strong> RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pa<strong>in</strong> cl<strong>in</strong>ical trials:<br />
IMMPACT recommendations. Pa<strong>in</strong> 2005; 113: 9-19<br />
10. Jensen MP, McFarland CA. Increas<strong>in</strong>g the reliability and vali<strong>di</strong>ty of pa<strong>in</strong> <strong>in</strong>tensity measurement<br />
<strong>in</strong> chronic pa<strong>in</strong> patients. Pa<strong>in</strong> 1993, 55:195-203<br />
11. Preston CC, Colman AM. Optimal number of response categories <strong>in</strong> rat<strong>in</strong>g scales: Reliability,<br />
vali<strong>di</strong>ty, <strong>di</strong>scrim<strong>in</strong>at<strong>in</strong>g power, and respondent preferences. Acta Psychol (Amst) 2000; 104: 1-15<br />
12. Jensen MP, Turner JA, Romano JM. What is the maximum number of levels needed <strong>in</strong> pa<strong>in</strong><br />
<strong>in</strong>tensity measurement? Pa<strong>in</strong> 1994; 58: 387-392<br />
13. Farrar JT, Portenoy RK, Berl<strong>in</strong> JA, et al. Def<strong>in</strong><strong>in</strong>g the cl<strong>in</strong>ically important <strong>di</strong>fference <strong>in</strong> pa<strong>in</strong><br />
outcome measures. Pa<strong>in</strong> 88:287-294, 2000<br />
14. Farrar JT, Young JP Jr, LaMoreaux L, et al. Cl<strong>in</strong>ical importance of changes <strong>in</strong> chronic pa<strong>in</strong><br />
<strong>in</strong>tensity measured on an 11-po<strong>in</strong>t numerical pa<strong>in</strong> rat<strong>in</strong>g scale. Pa<strong>in</strong> 2001; 94:149-158<br />
15. Serl<strong>in</strong> RC, Mendoza TR, Nakamura Y, et al. When is cancer pa<strong>in</strong> mild, moderate or severe?<br />
grad<strong>in</strong>g pa<strong>in</strong> severity by its <strong>in</strong>terference with function. Pa<strong>in</strong> 1995; 61: 277-284<br />
16. Herr KA, Spratt K, Mobily PR, et al. Pa<strong>in</strong> <strong>in</strong>tensity assessment <strong>in</strong> older adults: Use of<br />
experimental pa<strong>in</strong> to compare psychometric properties and usability of selected pa<strong>in</strong> scales with<br />
younger adults. Cl<strong>in</strong> J Pa<strong>in</strong> 2004; 20:207-219<br />
17. Mercadante S, Radbruch L, Caraceni A, et al. Episo<strong>di</strong>c (breakthrough) pa<strong>in</strong>: Consensus<br />
conference of an expert work<strong>in</strong>g group of the european association for palliative care. Cancer 2002;<br />
94:832-839<br />
18. Portenoy RK, Payne D, Jacobsen P. Breakthrough pa<strong>in</strong>. Characteristics and impact <strong>in</strong> patients<br />
with cancer pa<strong>in</strong>. Pa<strong>in</strong> 1999; 81:129-134<br />
19. Hagen NA, Stiles C, Nekolaichuk C, et al. The Alberta Breakthrough Pa<strong>in</strong> Assessment Tool for<br />
cancer patients: A validation study us<strong>in</strong>g a <strong>del</strong>phi process and patient th<strong>in</strong>k-aloud <strong>in</strong>terviews. J Pa<strong>in</strong><br />
Symptom Manage 2008; 35: 136-152<br />
20. Jensen MP, Chen C, Brugger AM. Postsurgical pa<strong>in</strong> outcome assessment. Pa<strong>in</strong> 2002; 99:101-<br />
109<br />
18